> top > docs > PMC:7253482 > spans > 2108-2310 > annotations

PMC:7253482 / 2108-2310 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
67 73-78 Gene denotes spike Gene:43740568

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T10 83-91 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T11 60-65 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T10 83-91 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T8 13-22 http://purl.obolibrary.org/obo/IDO_0000528 denotes pathogens

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T321 0-6 VB denotes combat
T322 7-12 DT denotes these
T323 13-22 NNS denotes pathogens
T324 24-31 VBG denotes Ongoing
T325 32-39 NN denotes vaccine
T326 40-51 NN denotes development
T327 52-59 NNS denotes efforts
T328 60-65 NN denotes focus
T329 66-68 IN denotes on
T330 69-72 DT denotes the
T331 73-78 NN denotes spike
T332 79-80 -LRB- denotes (
T333 80-81 NN denotes S
T334 81-82 -RRB- denotes )
T335 83-91 NNS denotes proteins
T336 92-96 WDT denotes that
T337 97-105 VBP denotes protrude
T338 106-110 IN denotes from
T339 111-114 DT denotes the
T340 115-120 JJ denotes viral
T341 121-129 NN denotes envelope
T342 130-133 CC denotes and
T343 134-144 VB denotes constitute
T344 145-148 DT denotes the
T345 149-153 JJ denotes main
T346 154-160 NN denotes target
T347 161-163 IN denotes of
T348 164-176 VBG denotes neutralizing
T349 177-190 NN denotes antibodies7,8
T350 192-197 DT denotes These
R318 T323 T321 arg2Of pathogens,combat
R319 T323 T322 arg1Of pathogens,these
R320 T328 T324 arg1Of focus,Ongoing
R321 T328 T325 arg1Of focus,vaccine
R322 T328 T326 arg1Of focus,development
R323 T328 T327 arg1Of focus,efforts
R324 T328 T329 arg1Of focus,on
R325 T335 T329 arg2Of proteins,on
R326 T335 T330 arg1Of proteins,the
R327 T335 T331 arg1Of proteins,spike
R328 T335 T332 arg1Of proteins,(
R329 T333 T332 arg2Of S,(
R330 T334 T332 arg3Of ),(
R331 T335 T336 arg1Of proteins,that
R332 T335 T337 arg1Of proteins,protrude
R333 T337 T338 arg1Of protrude,from
R334 T341 T338 arg2Of envelope,from
R335 T341 T339 arg1Of envelope,the
R336 T341 T340 arg1Of envelope,viral
R337 T337 T342 arg1Of protrude,and
R338 T343 T342 arg2Of constitute,and
R339 T335 T343 arg1Of proteins,constitute
R340 T346 T343 arg2Of target,constitute
R341 T346 T344 arg1Of target,the
R342 T346 T345 arg1Of target,main
R343 T346 T347 arg1Of target,of
R344 T348 T347 arg2Of neutralizing,of
R345 T349 T348 arg2Of "antibodies7,8",neutralizing

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T10 83-91 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T10 83-91 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T15 24-191 Sentence denotes Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
67 73-78 Gene denotes spike Gene:43740568

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T714 79-91 Protein denotes (S) proteins https://www.uniprot.org/uniprot/Q9UIP0|https://www.uniprot.org/uniprot/Q9UIN9|https://www.uniprot.org/uniprot/Q9UIN8|https://www.uniprot.org/uniprot/Q9UIN7|https://www.uniprot.org/uniprot/Q9UIN6|https://www.uniprot.org/uniprot/Q9UBH8|https://www.uniprot.org/uniprot/Q9NRH8|https://www.uniprot.org/uniprot/Q9NRH7|https://www.uniprot.org/uniprot/Q9NRH6|https://www.uniprot.org/uniprot/Q9NRH5|https://www.uniprot.org/uniprot/Q9NRH4|https://www.uniprot.org/uniprot/Q9NPG5|https://www.uniprot.org/uniprot/Q9NPE0|https://www.uniprot.org/uniprot/Q9NP52|https://www.uniprot.org/uniprot/Q95IF9|https://www.uniprot.org/uniprot/Q8N5P3|https://www.uniprot.org/uniprot/Q8IZU6|https://www.uniprot.org/uniprot/Q8IZU5|https://www.uniprot.org/uniprot/Q8IZU4|https://www.uniprot.org/uniprot/Q86Z04|https://www.uniprot.org/uniprot/Q7YR44|https://www.uniprot.org/uniprot/Q7LA71|https://www.uniprot.org/uniprot/Q7LA70|https://www.uniprot.org/uniprot/Q5STD2|https://www.uniprot.org/uniprot/Q5SQ85|https://www.uniprot.org/uniprot/Q1XI16|https://www.uniprot.org/uniprot/Q1XI12|https://www.uniprot.org/uniprot/Q15517|https://www.uniprot.org/uniprot/O43509|https://www.uniprot.org/uniprot/O19084|https://www.uniprot.org/uniprot/B0UYZ7|https://www.uniprot.org/uniprot/B0S7V2|https://www.uniprot.org/uniprot/A5A6L9

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T15 24-191 Sentence denotes Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.